| [1] | ZHAO ZJ,ZHAO C,XIAO J,et al. Transdermal permeation and anti-inflammation activities of novel sinomenine derivatives[J]. Molecules,2016,21(11):1520. |
| [2] | 高晨鑫,张湛明,陈继红,等. 青藤碱对类风湿关节炎细胞因子影响的研究进展[J]. 风湿病与关节炎,2017,6(2):72-75. |
| [3] | ZHAO XX,PENG C,ZHANG H,et al.Sinomenium acutum:A review of chemistry,pharmacology,pharmacokinetics,and clinical use[J]. Pharm Biol,2012,50(8),1053-1061. |
| [4] | 吴娟,李燕红. 正清风痛宁药物治疗的副作用及防治[J].中国医药导刊,2012,14(2):250-252. |
| [5] | 游素芬,戈萌.青藤碱的医药新用途:CN1679574[P]. 2005-10-12. |
| [6] | CHEN C,XU HQ,ZHONG J.New use of sinomenine:1149456[P].1997-05-14. |
| [7] | 秦峰,蔡辉. 青藤碱药理作用研究进展[J]. 现代中药研究与实践,2016(4):81-86. |
| [8] | HE L,DUAN H,LI X,et al. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis[J]. Eur J Pharmacol,2016,779:66-79. |
| [9] | HUANG L,LI T,ZHOU H,et al. Sinomenine potentiates degranulation of RBL-2H3 basophils via up-regulation of phospholipase A2 phosphorylation by Annexin A1 cleavage and ERK phosphorylation without influencing on calcium mobilization[J]. Int Immunopharmacol,2015,28(2):945-951. |
| [10] | LOU YT,ZHOU HB,ZOU J,et al.Modification of poorly bioactive sinomenine into morepotent immunosuppressive agents by embedding of drug-like fragments[J].Tetrahedron Lett,2010,51(3):485-488. |
| [11] | 姚祝军,周海滨. C环连接有吡嗪环的青藤碱衍生物、合成方法及其用途:1687065 A[P]. 2005-10-26. |
| [12] | 姚祝军,周海滨. C环连接有五元杂环的青藤碱衍生物和合成方法:1687070 A[P]. 2007-10-26. |
| [13] | TANG J,ZHANG R,XU XQ,et al. Synthesis,characterization,and NF-kappa B pathway inhibition of;1-halogenated sinomenine derivatives[J]. Chem Nat Comp,2013,48(6):1031-1034. |